… bias and exact treatment selection process, this study offers … in the therapy of pancreatic
cancer. Although these conclusions … to drive the selection of chemotherapy for pancreatic cancer. …

… the pharmacogenetic studies will allow the selection of more effective drugs. However,
the … selected on the basis of standard criteria versus treatment selection based on patient/cancer …

… We are hopeful that an era of better drug selections and therapeutic options are around the
corner for PDA patients. Yet, until 'personalized medicine' and better targeted therapies are …

… Selection of patient groups for specific therapy including cytotoxics is becoming a reality
using assays based on drug cellular transport and metabolism, and molecular signatures. Going …

… of targeted therapies in pancreatic cancer is … pancreatic cancer. Therefore, this review aims
to offer an updated perspective on biomarkers with therapeutic potential in pancreatic cancer. …

… seven candidate drugs for treating pancreatic cancer, three of which … validated to be inhibitory
to pancreatic cancer celllines. … randomly selected the same number of drugs significant to a …

… Several trials investigating novel combinations of immunotherapy, chemotherapy, and
vaccines in advanced pancreatic cancer are currently ongoing, a selection of which are described …

… is still no consensus on how to select treatment for pancreatic cancer upon progression of
disease. … All the potential second-line options offer limited survival benefit; thus, the selection of …

… We have also conducted selection, data extraction and quality assessment by two
reviewers independently, and we present the results with the respective certainty of evidence …

… We selected drugs for each tissue including chemotherapeutics and targeted agents approved
by the United States Food and Drug Administration (FDA), drugs in clinical development …